Alembic Pharmaceuticals informs about updates

16 Feb 2023 Evaluate

Alembic Pharmaceuticals has informed that the Company has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for the inspection carried out by them at its Injectable Facility (F-3) at Karkhadi from 18th August, 2022 to 30th August, 2022. This was a pre-approval inspection for ANDAs filed with the USFDA. The Company has already started receiving ANDA approvals manufactured at this facility.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

845.80 -3.10 (-0.37%)
19-Dec-2025 14:21 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1747.40
Dr. Reddys Lab 1272.95
Cipla 1510.05
Zydus Lifesciences 915.00
Lupin 2120.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×